Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT. - Wikidata - wikimedia - TriplyDB

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

http://www.wikidata.org/entity/Q53192471

about

Update on positron emission tomography for imaging of prostate cancer In vitro and in vivo evaluation of a (18)F-labeled high affinity NOTA conjugated bombesin antagonist as a PET ligand for GRPR-targeted tumor imaging Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.Detection and Characterization of Parathyroid Adenoma/Hyperplasia for Preoperative Localization: Comparison Between (11)C-Methionine PET/CT and (99m)Tc-Sestamibi Scintigraphy.Appropriateness criteria of FDG PET/CT in oncology.Molecular imaging of prostate cancer: PET radiotracers.PET/CT in prostate cancer: non-choline radiopharmaceuticals.(18)F-fluorodeoxyglucose PET/CT for detection of disease in patients with prostate-specific antigen relapse following radical treatment of a local-stage prostate cancer.The combination of 13N-ammonia and 18F-FDG whole-body PET/CT on the same day for diagnosis of advanced prostate cancer.Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy Translational Molecular Imaging of Prostate Cancer.Functional and molecular imaging of localized and recurrent prostate cancer.Radiopharmaceuticals as probes to characterize tumour tissue.Imaging of prostate cancer with PET/CT using (18)F-Fluorocholine.Clinical Significance of 18F-Fluorodeoxyglucose Avid Prostate Gland Incidentalomas on Positron Emission Tomography/Computed Tomography.PET Tracers Beyond FDG in Prostate Cancer.Advances in medical imaging for the diagnosis and management of common genitourinary cancers.Choline PET and PET/CT in Primary Diagnosis and Staging of Prostate Cancer.Diagnostic role of fluorodeoxyglucose positron emission tomography-computed tomography in prostate cancer.[Focus on molecular imaging in prostate cancer].Combined 18F-fluoride and 18F-FDG PET/CT: a response based on actual data from prospective studies.Molecular imaging and fusion targeted biopsy of the prostate.Comparison of meta-analyses among elastosonography (ES) and positron emission tomography/computed tomography (PET/CT) imaging techniques in the application of prostate cancer diagnosis.Multicentre study of 18F-FDG-PET/CT prostate incidental uptake

P2860

Q27026828-5D513EE1-34C7-465A-8BC9-FA7B13C1D9B6 Q28535729-58195CFD-5263-499C-A4B2-661254477A2D Q33625371-DCC998B7-CF67-42C8-8480-0CD4B8870ABC Q33669931-5382EF35-0EA8-4879-BFB5-B0231431D46A Q35568776-C1592DCA-8B41-4710-8714-59728B2AC145 Q36129937-99CA555A-DEDD-4C65-8702-564E5C7E4A46 Q36308766-1592CE22-1EC8-4F52-9555-FC94089733D0 Q36502692-B7BD6049-70D0-4717-80B2-6772EE665E75 Q36504085-A33F2C4F-FDD0-47C6-8640-5D91CFEE364C Q36798118-0A6BBD03-0B00-4A1E-AF01-CBC99CA555F3 Q37214430-9885E98C-F274-4DD6-84B1-2E091CB5E3D7 Q37244969-98EDF904-ECBF-44C5-93E0-887AF5710CC2 Q38104639-D517D01B-4B2F-4630-9B5E-64EFA34A5BBF Q38342458-E15E4D69-0867-4DBC-A61E-051E1E95D971 Q38479113-244A5F65-E984-4BCB-B468-EF0FE9FF6AD7 Q38726124-77A9E21D-B11A-4070-AE6F-22535414C87F Q39003086-CD3C7EA8-4290-446A-8D9F-64FAB24BE1D2 Q39307896-EE315737-BF9D-4807-A8DA-6843E7EA8EA0 Q39636721-D7950CBA-6E23-4474-AE18-89BFF39310B2 Q40448619-CFEA165A-0E13-4C20-912D-557C06ABEBB2 Q41585395-06567EEE-6ED2-46FF-9488-44F378491B95 Q44002717-0118DB5D-F0D1-43E5-B53E-C5413B68B6DA Q47608215-8AAA9D5E-A284-4C71-8941-1D724DD2A7F1 Q52990619-FF1C7149-A1DD-43A2-B3D5-E0AA1601073D Q58005219-301404B5-53A3-4E17-97DC-057CDAAB8EDE

P2860

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

http://www.wikidata.org/entity/Q53192471

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh-hant

name

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@en

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@nl

type

label

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@en

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@nl

prefLabel

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@en

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@nl

P1433

Q53192471-B4F6F440-901B-459F-A272-FF56C5E688F1

P1476

Q53192471-AD97ADC2-04E5-453D-8FCC-9CC75047AC89

P2093

Q53192471-00034767-E445-4D14-9A51-C12B3BC2F93E

Q53192471-0EC3B0C7-8350-443D-93B4-351C4A4DD532

Q53192471-4728E2E0-81D5-4590-814E-3285CAA6ACC3

Q53192471-57CB4B49-73B0-4456-B146-CA10C7C48D5E

Q53192471-8A943128-F19C-468D-B83C-CF623C95575F

Q53192471-98713715-C338-413E-A9E7-345570CFFB7C

Q53192471-BC176BD7-9081-4EDE-B05C-5B393E42F672

Q53192471-C1A92F86-5B86-4518-93D6-C2122C69072C

Q53192471-D49A91EA-C86A-484D-822E-2B5C83D122A1

P2860

Q53192471-0A6171D3-E2FA-456E-A72B-B32A8783529D

Q53192471-166C9BCA-0647-4FC2-8342-E8862A3B6826

Q53192471-26B9E767-8CD3-4144-B10E-30F109066DD7

Q53192471-428E0D35-9264-42A5-8343-D8A8587EC90C

Q53192471-4F2E4593-6DA1-448A-BC44-89816302039A

Q53192471-6A7246C0-DC39-483F-92BC-616985FC7623

Q53192471-85A9F64B-DC39-4E3D-9432-C7D7C5FFD0D1

Q53192471-88441387-2629-405E-9E65-5A327F5A64B4

Q53192471-888E11EB-D7BD-410B-AC6E-C0170EB17C4D

Q53192471-89424EC7-A6FD-4B01-B4B9-88842A303DA2

P2888

Q53192471-B4FBDD27-1D27-4907-8233-AD4C329ECA20

P304

Q53192471-720DEC38-72AB-4E60-A9D2-5079BD633966

P31

Q53192471-EA8406C2-59A5-4E2D-B2DF-4977E40FB556

P356

Q53192471-9EF5E449-352B-4ED9-8A70-8C6950359F1C

P433

Q53192471-FB01FFF7-096D-4B29-941F-3B91295E77B9

P478

Q53192471-DD1EDEA4-0958-40E1-BF39-D4A8EAC2EC29

P577

Q53192471-0D362ED5-C025-4994-BDA4-28FBE88EFBFF

P5875

Q53192471-D6941B20-2C0D-40D5-96BD-787C49EABD9D

P698

Q53192471-BF20D826-ACB2-45DA-B5C1-80A6A2B9AA8E

P356

S12149-011-0551-6

P1433

Annals of Nuclear Medicine

P1476

Evaluation of primary prostate cancer using 11C-methionine-PET/CT and 18F-FDG-PET/CT.

@en

P2093

Go Kimura

http://www.w3.org/2001/XMLSchema#string

Hidetaka Sato

http://www.w3.org/2001/XMLSchema#string

Hisashi Yoshihara

http://www.w3.org/2001/XMLSchema#string

Keiichi Ishihara

http://www.w3.org/2001/XMLSchema#string

Masato Shiiba

http://www.w3.org/2001/XMLSchema#string

Shin-ichi Tsuchiya

http://www.w3.org/2001/XMLSchema#string

Shin-ichiro Kumita

http://www.w3.org/2001/XMLSchema#string

Tomoyuki Kuwako

http://www.w3.org/2001/XMLSchema#string

Yukihiro Kondo

http://www.w3.org/2001/XMLSchema#string

P2860

The meaning and use of the area under a receiver operating characteristic (ROC) curve

Cancer statistics, 2009

Fluorodeoxyglucose positron emission tomography studies in diagnosis and staging of clinically organ-confined prostate cancer.

Prostate cancer staging: should MR imaging be used?--A decision analytic approach.

A method of comparing the areas under receiver operating characteristic curves derived from the same cases.

Positron emission tomography for prostate, bladder, and renal cancer.

MR imaging and MR spectroscopic imaging in the pre-treatment evaluation of prostate cancer.

The clinical advances of fluorine-2-D-deoxyglucose--positron emission tomography/computed tomography in urological cancers.

A clinically relevant approach to imaging prostate cancer: review.

Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging.

P2888

s12149-011-0551-6

P304

138-145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12149-011-0551-6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51784981

http://www.w3.org/2001/XMLSchema#string

P698

22069194

http://www.w3.org/2001/XMLSchema#string